Heart, Lung and Circulation
Volume 18, Issue 1 , Pages 38-44 , February 2009

Changes in Tissue-Doppler Echocardiographic Assessment of Left Ventricular Filling During NT-proBNP Guided Heart Failure Treatment Titration: A Pilot Study

  • Cara A. Wasywich, MBChB

      Affiliations

    • Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92024, Auckland 1031, New Zealand
    • Corresponding Author InformationCorresponding author. Tel.: +64 9 307 4949; fax: +64 9 307 4950.
    • ,
  • Gillian A. Whalley, PhD

      Affiliations

    • Cardiovascular Research Laboratory, Department of Medicine, University of Auckland, Auckland, New Zealand
    • ,
  • Helen A. Walsh, BSc

      Affiliations

    • Cardiovascular Research Laboratory, Department of Medicine, University of Auckland, Auckland, New Zealand
    • ,
  • Greg D. Gamble, MSc

      Affiliations

    • Cardiovascular Research Laboratory, Department of Medicine, University of Auckland, Auckland, New Zealand
    • ,
  • Robert N. Doughty, MD

      Affiliations

    • Cardiovascular Research Laboratory, Department of Medicine, University of Auckland, Auckland, New Zealand

Received 15 August 2007 ,Revised 1 May 2008 ,Accepted 20 July 2008.

References 

  1. The SOLVD Investigators . Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med. 1991;325:293–302
  2. The CONSENSUS Trial Study Group . Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Eng J Med. 1987;316:1429–1435
  3. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial – the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355(May (9215)):1582–1587
  4. CIBIS-II, Investigators, and, Committees . The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13
  5. MERIT-HF, Study, Group . Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353:2001–2007
  6. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Eng J Med. 2001;344(May (22)):1651–1658
  7. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Eng J Med. 2003;348(April (14)):1309–1321
  8. Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Eng J Med. 1999;341(September (10)):709–717
  9. Stewart S, MacIntyre K, MacLeod MMC, Bailey AEM, Capewell S, McMurray JJV. Trends in hospitalization for heart failure in Scotland, 1990–96. Eur Heart J. 2001;22(February (3)):209–217
  10. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. The Lancet. 2000;355(April):1126–1130
  11. Steimle AE, Warner Stevenson L, Chelimsky-Fallick C, Fonarow G, Hamilton MA, Moriguchi JD, et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation. 1997;96(4):1165–1172
  12. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol. 2006;47(Feb (4)):742–748
  13. Murdoch DR, McDonagh T, Byrne J, Blue L, Farmer R, Morton JJ, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the haemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J. 1999;138(6, part 1):1126–1132
  14. Abali G, Tokgozoglu L, Ozcebe OI, Aytemir K, Nazli N. Which Doppler parameters are load independent? A study in normal volunteers after blood donation. J Am Soc Echocardiogr. 2005;18(December (12)):1260–1265
  15. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. A comparative simultaneous Doppler-catheterisation study. Circulation. 2000;102:1788–1794
  16. Nagueh S, Middleton K, Koplen H. Doppler tissue imaging: a non-invasive technique for evaluation of left ventricular relaxation and estimation of left ventricular filling pressures. J Am Coll Cardiol. 1997;30:1527–1533
  17. Dokainish H, Zoghbi WA, Lakkis NM, Quinones MA, Nagueh SF. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol. 2004;93(May (9)):1130–1135
  18. Hillis GS, Moller JE, Pellikka PA, Gersh BJ, Wright RS, Ommen SR, et al. Noninvasive estimation of left ventricular filling pressure by E/e’ is a powerful predictor of survival after myocardial infarction. J Am Coll Cardiol. 2004;43(3):360–367
  19. Wang M, Yip GWK, Wang AYM, Zhang Y, Ho PY, Tse MK, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003;41(5):820–826
  20. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) developed in collaboration with the international society for heart and lung transplantation endorsed by the heart failure society of America 12345. J Am Coll Cardiol. 2001;38(7):2101–2113
  21. Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ, et al. Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrendergic receptor density in humans. J Am Coll Cardiol. 2000;36(3):891–896
  22. Warner Stevenson L, Dracup KA, Tillish JH. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol. 1989;63(7):461–464
  23. The ESCAPE investigators and ESCAPE study coordinators . Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294(October (13)):1625–1633
  24. Doughty RN, Wright SP, Pearl A, Walsh HJ, Muncaster S, Whalley GA, et al. Randomized, controlled trial of integrated heart failure management: the Auckland Heart Failure Management Study. Eur Heart J. 2002;23:139–146
  25. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, et al. The prognosis of heart failure in the general population. The Rotterdam Study. Eur Heart J. 2001;22(15):1318–1327
  26. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, et al. Incidence and aetiology of heart failure: a population based study. Eur Heart J. 1999;20(March (6)):421–428
  27. McDonald K. Current guidelines in the management of chronic heart failure: practical issues in their application to the community population. Eur J Heart Failure. 2005;7:317–321
  28. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol. 2004;43(February (3)):416–422
  29. Mak GS, DeMaria AN, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J. 2004;148:895–902
  30. Mottram PM, Haluska BA, Marwick TH. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload. Am Heart J. 2004;148:365–370
  31. Dokainish H, Zoghbi WA, Lakkis NM, Al-Bakshy F, Dhir M, Quinones MA, et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation. 2004;109:2432–2439
  32. Khan S, Bess RL, Rosman HS, Nordstrom CK, Cohen GI, Gardin JM. Which echocardiographic Doppler left ventricular diastolic function measurements are most feasible in the clinical echocardiographic laboratory. Am J Cardiol. 2004;94(October):1099–1101

PII: S1443-9506(08)00818-4

doi: 10.1016/j.hlc.2008.07.002

Heart, Lung and Circulation
Volume 18, Issue 1 , Pages 38-44 , February 2009

Article Tools

* Image Usage & Resolution